BrainStorm Partners with Minaris for NurOwn ALS Trials
May 27, 2025
BrainStorm Cell Therapeutics, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced that it has signed a Letter of Intent (LOI) with Minaris